These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 9517440

  • 21. Amisulpride the 'atypical' atypical antipsychotic--comparison to haloperidol, risperidone and clozapine.
    Natesan S, Reckless GE, Barlow KB, Nobrega JN, Kapur S.
    Schizophr Res; 2008 Oct; 105(1-3):224-35. PubMed ID: 18710798
    [Abstract] [Full Text] [Related]

  • 22. Expression of the D3 dopamine receptor in peptidergic neurons of the nucleus accumbens: comparison with the D1 and D2 dopamine receptors.
    Le Moine C, Bloch B.
    Neuroscience; 1996 Jul; 73(1):131-43. PubMed ID: 8783237
    [Abstract] [Full Text] [Related]

  • 23. Induction of c-fos mRNA in rat medial prefrontal cortex by antipsychotic drugs: role of dopamine D2 and D3 receptors.
    Merchant KM, Figur LM, Evans DL.
    Cereb Cortex; 1996 Jul; 6(4):561-70. PubMed ID: 8670682
    [Abstract] [Full Text] [Related]

  • 24. Influence of typical and atypical antipsychotics on neuropeptide Y-like immunoreactivity and NPY mRNA expression in rat striatum.
    Obuchowicz E, Turchan J.
    Neuropeptides; 1998 Oct; 32(5):473-80. PubMed ID: 9845010
    [Abstract] [Full Text] [Related]

  • 25. Differential regulation of D2 and D4 dopamine receptor mRNAs in the primate cerebral cortex vs. neostriatum: effects of chronic treatment with typical and atypical antipsychotic drugs.
    Lidow MS, Goldman-Rakic PS.
    J Pharmacol Exp Ther; 1997 Nov; 283(2):939-46. PubMed ID: 9353417
    [Abstract] [Full Text] [Related]

  • 26. Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study.
    Moghaddam B, Bunney BS.
    J Neurochem; 1990 May; 54(5):1755-60. PubMed ID: 1969939
    [Abstract] [Full Text] [Related]

  • 27. Examining dopamine D3 receptor occupancy by antipsychotic drugs via [3H]7-OH-DPAT ex vivo autoradiography and its cross-validation via c-fos immunohistochemistry in the rat brain.
    Davoodi N, te Riele P, Langlois X.
    Eur J Pharmacol; 2014 Oct 05; 740():669-75. PubMed ID: 24967534
    [Abstract] [Full Text] [Related]

  • 28. The effects of antipsychotic drugs on the mRNA levels of serotonin 5HT2A and 5HT2C receptors.
    Buckland PR, D'Souza U, Maher NA, McGuffin P.
    Brain Res Mol Brain Res; 1997 Aug 05; 48(1):45-52. PubMed ID: 9379848
    [Abstract] [Full Text] [Related]

  • 29. Antipsychotic regulation of hippocampal dopamine receptor messenger RNA expression.
    Ritter LM, Meador-Woodruff JH.
    Biol Psychiatry; 1997 Aug 01; 42(3):155-64. PubMed ID: 9232207
    [Abstract] [Full Text] [Related]

  • 30. Neuroleptics with differential affinities at dopamine D2 receptors and sigma receptors affect differently the N-methyl-D-aspartate-induced increase in intracellular calcium concentration: involvement of protein kinase.
    Hayashi T, Su TP, Kagaya A, Nishida A, Shimizu M, Yamawaki S.
    Synapse; 1999 Jan 01; 31(1):20-8. PubMed ID: 10025680
    [Abstract] [Full Text] [Related]

  • 31. Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs.
    Florijn WJ, Tarazi FI, Creese I.
    J Pharmacol Exp Ther; 1997 Feb 01; 280(2):561-9. PubMed ID: 9023264
    [Abstract] [Full Text] [Related]

  • 32. Effects of l-stepholidine on forebrain Fos expression: comparison with clozapine and haloperidol.
    Mo YQ, Jin XL, Chen YT, Jin GZ, Shi WX.
    Neuropsychopharmacology; 2005 Feb 01; 30(2):261-7. PubMed ID: 15578005
    [Abstract] [Full Text] [Related]

  • 33. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum.
    Bruins Slot LA, Lestienne F, Grevoz-Barret C, Newman-Tancredi A, Cussac D.
    Eur J Pharmacol; 2009 Oct 12; 620(1-3):27-35. PubMed ID: 19695244
    [Abstract] [Full Text] [Related]

  • 34. Clozapine-, but not haloperidol-, induced increases in deltaFosB-like immunoreactivity are completely blocked in the striatum of mice lacking D3 dopamine receptors.
    Robertson GS, Lee CJ, Sridhar K, Nakabeppu Y, Cheng M, Wang YM, Caron MG.
    Eur J Neurosci; 2004 Dec 12; 20(11):3189-94. PubMed ID: 15579174
    [Abstract] [Full Text] [Related]

  • 35. Dopamine D1, D2 and serotonin2 receptor occupation by typical and atypical antipsychotic drugs in vivo.
    Matsubara S, Matsubara R, Kusumi I, Koyama T, Yamashita I.
    J Pharmacol Exp Ther; 1993 May 12; 265(2):498-508. PubMed ID: 7684443
    [Abstract] [Full Text] [Related]

  • 36. Alpha1-adrenergic, D1, and D2 receptors interactions in the prefrontal cortex: implications for the modality of action of different types of neuroleptics.
    Gioanni Y, Thierry AM, Glowinski J, Tassin JP.
    Synapse; 1998 Dec 12; 30(4):362-70. PubMed ID: 9826228
    [Abstract] [Full Text] [Related]

  • 37. Double activity imaging reveals distinct cellular targets of haloperidol, clozapine and dopamine D(3) receptor selective RGH-1756.
    Kovács KJ, Csejtei M, Laszlovszky I.
    Neuropharmacology; 2001 Mar 12; 40(3):383-93. PubMed ID: 11166331
    [Abstract] [Full Text] [Related]

  • 38. Atypical neuroleptic drugs downregulate dopamine sensitivity in rat cortical and striatal astrocytes.
    Reuss B, Unsicker K.
    Mol Cell Neurosci; 2001 Aug 12; 18(2):197-209. PubMed ID: 11520180
    [Abstract] [Full Text] [Related]

  • 39. Lack of dopamine supersensitivity in rats after chronic administration of blonanserin: Comparison with haloperidol.
    Hashimoto T, Baba S, Ikeda H, Oda Y, Hashimoto K, Shimizu I.
    Eur J Pharmacol; 2018 Jul 05; 830():26-32. PubMed ID: 29684390
    [Abstract] [Full Text] [Related]

  • 40. The antipsychotics olanzapine, risperidone, clozapine, and haloperidol are D2-selective ex vivo but not in vitro.
    McCormick PN, Kapur S, Graff-Guerrero A, Raymond R, Nobrega JN, Wilson AA.
    Neuropsychopharmacology; 2010 Jul 05; 35(8):1826-35. PubMed ID: 20410873
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.